Galapagos reported -46750000 in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
AstraZeneca AZN:LN 1.13B 768M
Biogen BIIB:US $ 794M 308.3M
Genmab GEN:DC 787M 255M
Gilead Sciences GILD:US $ 2246M 644M
GlaxoSmithKline GSK:LN 1.68B 18M
GRIFOLS GRF:SM € 250.6M 37.64M
H. Lundbeck A/S LUN:DC 596M 286M
Hikma Pharmaceutical HIK:LN 343M 34M
Merck MRK:GR € 1049M 6M
Neurocrine Biosciences NBIX:US $ 62.8M 31.3M
Novartis NOVN:VX 3.48B 1.06B
Vertex Pharmaceuticals VRTX:US $ -37.96M 925.79M
YTE INCY:US $ 140.84M 42.04M